Add to ORKGNew oncological approaches using immune checkpoint inhibitors aim to reinvigorate lymphocytes against the tumor. The prognosis of cancer has been significantly improved by these treatments, which nonetheless lead to a new spectrum of immune-related side effects. The most frequent are skin rash, colitis, thyroid dysfunction, hypophysitis, hepatitis and pneumonitis. Early detection of these toxicities is crucial to determine the etiology and to introduce a temporary immunosuppressive therapy, allowing resolution of toxicity in most of cases. A multidisciplinary team is essential for optimal management
Within the past decade, immune-checkpoint inhibitors (ICPIs), including anti-programmed cell death 1...
Targeted immune checkpoint blockade augments anti-tumor immunity and induces durable responses in pa...
Immune checkpoint inhibitors (ICIs) block inhibitory molecules, such as cytotoxic T-lymphocyte-assoc...
New oncological approaches using immune checkpoint inhibitors aim to reinvigorate lymphocytes agains...
The next decade in cancer therapy will be marked by the expansion of immunotherapies, namely immune ...
The introduction into clinical practice of immune checkpoint inhibitors that block cytotoxic T-lymph...
International audienceUse of checkpoint inhibitors to treat cancer was one of the most important rev...
The immune checkpoint inhibitors (ICI) have radically changed the treatment and the prognostic of ce...
Abstract Cancer immunotherapy has transformed the treatment of cancer. However, increasing use of im...
Immune checkpoint inhibitors have radically changed oncology by significantly improving prognosis an...
Novel cancer immunotherapy antibodies are moving from clinical trials into routine practice, deliver...
Immunotherapy through checkpoint inhibitors is now standard practice for a growing number of cancer ...
Immunotherapy, which stimulates the body’s immune system, has received a considerable amount of pres...
Immunotherapy is considered to be the most important breakthrough in cancer management in the past f...
editorial reviewedImmunotherapy has revolutionized cancer management in recent years and is affectin...
Within the past decade, immune-checkpoint inhibitors (ICPIs), including anti-programmed cell death 1...
Targeted immune checkpoint blockade augments anti-tumor immunity and induces durable responses in pa...
Immune checkpoint inhibitors (ICIs) block inhibitory molecules, such as cytotoxic T-lymphocyte-assoc...
New oncological approaches using immune checkpoint inhibitors aim to reinvigorate lymphocytes agains...
The next decade in cancer therapy will be marked by the expansion of immunotherapies, namely immune ...
The introduction into clinical practice of immune checkpoint inhibitors that block cytotoxic T-lymph...
International audienceUse of checkpoint inhibitors to treat cancer was one of the most important rev...
The immune checkpoint inhibitors (ICI) have radically changed the treatment and the prognostic of ce...
Abstract Cancer immunotherapy has transformed the treatment of cancer. However, increasing use of im...
Immune checkpoint inhibitors have radically changed oncology by significantly improving prognosis an...
Novel cancer immunotherapy antibodies are moving from clinical trials into routine practice, deliver...
Immunotherapy through checkpoint inhibitors is now standard practice for a growing number of cancer ...
Immunotherapy, which stimulates the body’s immune system, has received a considerable amount of pres...
Immunotherapy is considered to be the most important breakthrough in cancer management in the past f...
editorial reviewedImmunotherapy has revolutionized cancer management in recent years and is affectin...
Within the past decade, immune-checkpoint inhibitors (ICPIs), including anti-programmed cell death 1...
Targeted immune checkpoint blockade augments anti-tumor immunity and induces durable responses in pa...
Immune checkpoint inhibitors (ICIs) block inhibitory molecules, such as cytotoxic T-lymphocyte-assoc...